Wolfe Research lowered Roivant Sciences (ROIV) to Peer Perform from Outperform. The note did not include a price target or further commentary. The downgrade signals a neutral view but lacks a detailed catalyst.
One free account opens every story complete, the live board, the 30-day calendar, a watchlist and breaking alerts on your phone. No card. The wire stays free to read.
